[go: up one dir, main page]

WO2006026358A3 - Sperm specific raft associated proteins - Google Patents

Sperm specific raft associated proteins Download PDF

Info

Publication number
WO2006026358A3
WO2006026358A3 PCT/US2005/030261 US2005030261W WO2006026358A3 WO 2006026358 A3 WO2006026358 A3 WO 2006026358A3 US 2005030261 W US2005030261 W US 2005030261W WO 2006026358 A3 WO2006026358 A3 WO 2006026358A3
Authority
WO
WIPO (PCT)
Prior art keywords
associated proteins
sperm specific
raft associated
specific raft
sperm
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/030261
Other languages
French (fr)
Other versions
WO2006026358A2 (en
Inventor
Susan B Sleight
John C Herr
Bingfang Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UVA Licensing and Ventures Group
University of Virginia UVA
Original Assignee
University of Virginia UVA
University of Virginia Patent Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Virginia UVA, University of Virginia Patent Foundation filed Critical University of Virginia UVA
Publication of WO2006026358A2 publication Critical patent/WO2006026358A2/en
Anticipated expiration legal-status Critical
Publication of WO2006026358A3 publication Critical patent/WO2006026358A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

The present invention is directed to mouse and human Band 10 and/or TES101 sperm proteins and the use of these proteins to prepare and isolate compounds that can be used as diagnostic and contraceptive agents.
PCT/US2005/030261 2004-08-25 2005-08-25 Sperm specific raft associated proteins Ceased WO2006026358A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60461704P 2004-08-25 2004-08-25
US60/604,617 2004-08-25

Publications (2)

Publication Number Publication Date
WO2006026358A2 WO2006026358A2 (en) 2006-03-09
WO2006026358A3 true WO2006026358A3 (en) 2009-05-07

Family

ID=36000577

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/030261 Ceased WO2006026358A2 (en) 2004-08-25 2005-08-25 Sperm specific raft associated proteins

Country Status (1)

Country Link
WO (1) WO2006026358A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118598971A (en) * 2024-07-01 2024-09-06 华南农业大学 Preparation method and application of porcine IZUMO2 eukaryotic protein and monoclonal antibody thereof
CN120441677B (en) * 2025-07-10 2025-09-12 深圳普迪特生命科技有限公司 A TEX101 recombinant protein-specific antibody, encoding gene, and use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000043495A2 (en) * 1999-01-19 2000-07-27 Human Genome Sciences, Inc. 33 human secreted proteins

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000043495A2 (en) * 1999-01-19 2000-07-27 Human Genome Sciences, Inc. 33 human secreted proteins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SANCHEZ ET AL.: "Generation and initial analysis of more than 15,000 full-Iength human and mouse cDNA sequences.", NATURE., vol. 99, no. 26, December 2002 (2002-12-01), pages 16899 - 16903 *

Also Published As

Publication number Publication date
WO2006026358A2 (en) 2006-03-09

Similar Documents

Publication Publication Date Title
WO2004039956A3 (en) Compositions and methods for the treatment of immune related diseases
WO2005032471A3 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
WO2003024392A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003000113A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003088808A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2006029183A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2005004803A3 (en) Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer's disease
WO2004001019A3 (en) Novel nanoparticles and use thereof
WO2002074337A8 (en) Hmgb1 protein inhibitors and/or antagonists for the treatment of vascular diseases
WO2003099771A3 (en) Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
EP1445317A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004024068A3 (en) Novel composition and methods for the treatment of immune related diseases
WO2005004802A3 (en) N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease
WO2004062625A3 (en) Macrocyclic beta-secretase inhibitors for treatment of alzheimer's disease
WO2003066661A3 (en) Human dr4 antibodies and uses thereof
WO2005051914A8 (en) Benzylether and benzylamino beta-secretase inhibitors for the treatment of alzheimer's disease
WO2005018545A3 (en) Macrocyclic beta-secretase inhibitors for the treatment of alzheimer's disease
AU2003290605A8 (en) Compositions and methods for the diagnosis and treatment of sepsis
WO2002016581A3 (en) Compositions and methods for the diagnosis and treatment of tumor
IL164647A0 (en) Oil body associated protein compositions and methods of use thereof for reducing the risk of cardiovascular disease
WO2004024072A3 (en) Novel compositions and methods for the treatment of immune related diseases
WO2004024063A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2002016602A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2004096124A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2006110760A3 (en) Compositions and methods for the diagnosis and treatment of tumor

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase